New Trends in Vaccine Manufacture - From Egg to Bioreactor - METTLER TOLEDO
White Paper

New Trends in Vaccine Manufacture - From Egg to Bioreactor

White Paper
From Egg to Bioreactor
From Egg to Bioreactor

Increasing worldwide demand for vaccines is resulting in manufacturers changing their production methods. Slow, chicken egg-based techniques are being replaced by much faster mammalian cell-culture fermentation. This white paper outlines vaccine manufacture based on biotechnology, and discusses the important role of the latest process analytical technology in maximizing production yield.

Find out:

  • how control of pH, dissolved oxygen, and dissolved CO2 levels affect mammalian cell culture productivity
  • the importance of analytical measurements in downstream processes
  • a recent development in sensor technology that increases fermentation process reliability

 

This page is not optimized for your web browser. Consider using a different browser or upgrade your browser to the latest version to ensure the best experience.